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Abstract
Objective, design and methods: Roux-en-Y gastric bypass (RYGB) has proved successful in attaining sustained weight 
loss but may lead to metabolic bone disease. To assess impact on bone mass and structure, we measured a real bone 
mineral density at the hip and spine by dual-energy X-ray absorptiometry, and volumetric BMD (vBMD) and bone 
microarchitecture at the distal radius and tibia by high-resolution peripheral quantitative CT in 25 morbidly obese 
subjects (15 females, 10 males) at 0, 12 and 24 months after RYGB. Bone turnover markers (BTMs), calciotropic and gut 
hormones and adipokines were measured at the same time points.
Results: After a 24.1% mean weight loss from baseline to month 12 (P < 0.001), body weight plateaued from month 
12 to 24 (−0.9%, P = 0.50). However, cortical and trabecular vBMD and microarchitecture deteriorated through the 
24 months, such that there was a 5 and 7% reduction in estimated bone strength at the radius and tibia respectively 
(both P < 0.001). The declines observed in the first 12 months were matched or exceeded by declines in the 12- to 
24-month period. While a significant increase in BTMs and decrease in leptin and insulin were seen at 24 months, 
these changes were maximal at month 12 and stabilized from month 12 to 24.
Conclusions: Despite weight stabilization and maintenance of metabolic parameters, bone loss and deterioration in 
bone strength continued and were substantial in the second year. The clinical importance of these changes in terms of 
increased risk of developing osteoporosis and fragility fractures remain an important concern.
Introduction
Morbid obesity is an increasing health problem and is 
associated with a substantial increase in mortality rate 
attributed to a number of co-morbid conditions (1). 
Conservative treatment with dietary and other lifestyle 
interventions often prove unsuccessful since an initial 
weight loss is followed by a renewed, often surplus weight 
gain (2). A number of surgical procedures and Roux-en-Y 
gastric bypass (RYGB) in particular, have proved successful 
in attaining sustained weight loss, lower mortality rates 
and improve or even resolve some co-morbid conditions 
such as type 2 diabetes mellitus (3, 4).
The main weight loss after RYGB occurs within the first 
six to twelve months and body weight then plateaus or 
slightly increases in the following years (4). Bone mineral 
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density (BMD) in the spine and hip rapidly declines in 
the first year after surgery which likely represents a 
skeletal adaptation to the lower body weight (5, 6, 7, 8). 
The few studies that have assessed long-term bone effects 
after RYGB indicate that bone loss continues even after 
weight loss has ceased (9, 10) suggesting that post-RYGB 
induced metabolic changes may have effects beyond 
those outplayed in the acute weight loss phase and may 
thus represent an unintended effect of the procedure. The 
potential mechanisms include a diminished gastric and 
short bowel area available for vitamin and nutritional 
uptake causing lower calcium absorption and vitamin D 
insufficiency leading to secondary hyperparathyroidism. 
Also, the levels of a number of intestinal hormones and 
cytokines are altered. The extent to which such changes 
have long-term deleterious effects on bone health are 
unknown (11).
The valid assessment of bone status in obese subjects 
using dual-energy X-ray absorptiometry (DXA) are 
diminished by technical constraints where soft-tissue 
artefacts may cause unpredictable impacts on BMD (11). 
Also DXA has lower precision with increasing body 
mass index (12). In obese subjects, these constraints 
appear to be less pronounced when BMD is measured 
based on three-dimensional imaging using quantitative 
computed tomography (QCT) in comparison to DXA 
(13). Further, with the use of newer 3D imaging systems 
with improved resolution, such as high-resolution 
peripheral QCT (HR-pQCT), the differential effects in 
various bone compartments may be disentangled with 
the assessment of geometry, volumetric BMD (vBMD) 
and microarchitecture in both the cortical and trabecular 
compartments in radius and tibia (14). A few studies 
have evaluated bone changes after bariatric surgery 
using this technique. In a cohort of patients treated with 
RYGB, gastric banding or sleeve gastrectomy, Stein et al. 
(6) found declines in cortical thickness and vBMD at 
the tibia 12  months post-surgery. Previously, we have 
shown substantial declines in indices of both cortical and 
trabecular BMD and microarchitecture as well as estimated 
strength at the tibia while only few changes at the radius 
12 months after RYGB (15). Similar results were reported 
in a study by Yu et al. (10) that found similar changes in 
tibia after 12 months and reported continued bone loss 
in both radius and tibia assessed 24 months after surgery.
In this two-year extension study, we report changes 
in HR-pQCT-based compartmental geometry, vBMD, 
microarchitecture and estimated strength, as well as 
biochemical markers of bone turnover, calciotropic 
hormones and adipokines after RYGB. We hypothesized 
that bone loss would be more pronounced at the tibia 
compared to the radius and that the changes from baseline 
to 24 months compared to 12 months would generally be 
mitigated as body weight plateaued.
Subjects and methods
Participants
We recruited 25 obese subjects eligible for RYGB (Fig. 1) 
using Danish guideline criteria (age >25 years and body 
mass index (BMI) >50 kg/m2 or BMI >35 kg/m2 along with 
at least one obesity-related complication) and planned 
for surgery, from the Department of Endocrinology, 
Odense University Hospital and the Department of 
Endocrinology, Hospital of Southwest Denmark between 
October 2011 and August 2012 as previously described 
(16). In brief, subjects were excluded if they were 
non-ambulatory, pregnant, perimenopausal or had 
metabolic bone disease including osteoporosis or used 
medications with known effects on bone metabolism at 
baseline. Subjects had study visits at 12 and 24 months 
of follow-up and participants were advised dietary 
recommendations as per local hospital guidelines. The 
study was approved by the Regional Scientific Ethical 
Committee for Southern Denmark. Informed consent 
was obtained from each subject after full explanation of 
the purpose and nature of all procedures used and the 
study was performed according to the guidelines of the 
Declaration of Helsinki.
Figure 1
Flowchart of inclusion.
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DXA
Areal BMD was measured at the total hip and lumbar 
spine (L1–L4) using DXA (Hologic, Waltham, MA, USA) at 
baseline, one and two years after surgery. The coefficient 
of variation (CV) is 1.5% at both the spine and hip in 
our unit. Also, a whole body DXA scan was performed to 
measure total fat and lean body mass. Quality control was 
maintained with daily measurement of a Hologic DXA 
spine phantom.
HR-pQCT
Geometry, volumetric BMD (vBMD) and microarchitecture 
of the distal radius and tibia were assessed using HR-pQCT 
(XtremeCT, Scanco Medical, Switzerland) at months 0, 
12 and 24. The standard protocol for image acquisition 
and analyses was applied as described previously (14), 
and a detailed description of the measurement protocol 
at our centre is described in (15). Quality control was 
performed daily and up to three scans at each site were 
obtained to get optimum image quality. Post-acquisition 
image grading was performed by one author (STH). An 
automatic common region matching procedure based 
on variation in bone cross-sectional area was applied to 
ensure that only volumes common to scans obtained at 
all visits were used for the extraction of parameters. An 
additional image evaluation was performed to further 
assess details of the cortical bone compartment as 
described previously (17). Also, radius and tibia bone 
failure load was estimated using a finite element analyses 
solver (Finite Element Analysis Software version 1.15, 
Scanco Medical) (18). In our unit, the CV for geometry, 
vBMD and microarchitecture measures at the radius ranges 
from 0.3 to 1.7%, 0.6 to 0.9% and 3.9 to 7.2% respectively, 
and the CV for geometry, vBMD and microarchitecture 
measures at the tibia ranges from for 0.2 to 1.2%, 0.4 to 
0.6% and 3.7 to 7.0% respectively, as detailed elsewhere 
(19). The CVs for estimated failure load were 1.7 and 1.2% 
at the radius and tibia respectively.
Biochemical analyses
A fasting blood sample was obtained at each visit. We 
measured parathyroid hormone (PTH) (Immunolite 
2000, Siemens), 25-OH-vitamin D (Cobas e411, Roche 
Diagnostics), follicle stimulating hormone (FSH) and 
luteinizing hormone (LH) (both AutoDelfia, Perkin 
Elmer). For these analyses the coefficient of variation 
(CV) ranged from 4 to 6%. Adiponectin and leptin were 
measured (Bio-Plex Pro assay, Bio-Rad Laboratories) as were 
procollagen type I amino-terminal propeptide (P1NP) and 
C-terminal telopeptide of type 1 collagen (CTX-I) ((iSYS, 
Immunodiagnostic Systems) with CV for these analyses 
ranging from 8 to 10%. Last, insulin (Elecsys 2010, Roche 
Diagnostics) was measured with a CV of 3.5%.
Statistical analyses
We report data as mean ± s.d. or median (interquartile 
range) as appropriate. Repeated measures ANOVA with 
time-wise comparisons were performed to compare 
values between the baseline, one and two year’s visits. 
Spearman’s correlation analysis was performed to assess 
predictors of bone loss (baseline age and weight as well 
as changes in weight, lean mass, ratio of lean mass to 
fat mass and biochemical indices from baseline to two 
years). As this is the first study exploring the predictors 
of changes in bone microarchitecture post-RYGB, our 
intention was to report our findings in a broader context 
and generate hypotheses. Hence, we did not formally 
adjust for multiple comparisons, but have interpreted our 
findings cautiously. A P-value below 0.05 was considered 
significant. All statistical analyses were performed using 
Stata Statistical Software release 11.0 (StataCorp LP).
Results
Study population characteristics
Of the 25 subjects at baseline, one subject missed the 
one year visit but was examined at the remainder time 
points and thus all 25 subjects were available for the 
two-year study. Two female participants were excluded 
since they entered menopause during the study period 
as judged from debut of irregular periods and a rapid 
rise in gonadotrophins. Therefore, a total of 23 subjects 
(one post- and 13 pre-menopausal women, 9 men) 
were included in the two-year analyses (Table  1). Six 
participants had type 2 diabetes and all received anti-
diabetic treatment at baseline whereas this was required 
in only one patient at the one- and two-year visits. One 
participant had type 1 diabetes.
Body weight
A median weight loss of 32 kg (range 3–59) was obtained 
from baseline to month 12 (−24.1%, P < 0.001) whereas 
body weight then levelled out and did not change from 
month 12 to 24 (−0.9%, P = 0.50).
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Biochemistry
Serum PTH remained stable throughout the 24-month 
study (Table  1). However, there was a persistent and 
significant increase in 25-OH-vitamin D at follow-up 
month 12 and month 24 (109.2 and 240.4% respectively, 
both P < 0.001). In comparison to baseline, there was 
a marked increase in P1NP and CTX1 after 12 months 
(113.6 and 166.7% respectively, both P < 0.001), and 
while P1NP did not change and CTX1 decreased from 
month 12 to 24 (−43.8%, P < 0.001), the median P1NP 
and CTX1 remained 112.9% (P < 0.001) and 40.0% 
(P < 0.05) above baseline at 24  months respectively. 
Similarly, we found an initial 109.6% increase in 
median adiponectin levels after 12 months (P < 0.001), 
that although decreased by 25.3% during the 24-month 
follow-up in comparison to the 12-month values 
(P < 0.001), remained 62.0% above the baseline value 
(P < 0.001). On the other hand, serum leptin and insulin 
levels displayed a marked decrease after 12  months 
(−70.0 and −68.0% respectively, both P < 0.001), that 
stabilized from month 12 to 24 but persisted to be 
significantly lower than baseline levels (−77.2 and 
−73.5% respectively, both P < 0.001).
DXA
There was a significant decrease in mean total hip aBMD 
and spine aBMD after 12 (−8.2 and −3.5% respectively, both 
P < 0.001) and 24 months (−10.5 and −5.3% respectively, 
both P < 0.001) in comparison to baseline. However, while 
the mean total hip aBMD displayed persistent decrease, 
spine aBMD did not change from 12 to 24 month (−2.1%, 
P < 0.05 and −1.5%, P = 0.06 respectively). Further, we 
found a significant fall in total fat mass, fat percent and 
lean mass from baseline to month 12 (all P < 0.001), 
which stabilized and did not change from month 12 to 
24 (Table 1).
HR-pQCT
Bone geometry, vBMD, indices of bone microarchitecture 
and estimated bone strength deteriorated throughout 
the study period (Table 2). At the radius, in comparison 
to baseline measurements, cortical area declined 
significantly (−3.2%, P < 0.01) whereas trabecular area 
did not change at month 24 (0.7%, P = 0.07). Total 
vBMD declined by 4.3% from baseline to month 24 
(P < 0.001) and was predominantly contributed by a 
Table 1 General characteristics, biochemistry and DXA results in patients at baseline, one and two years after gastric bypass 
surgery. Data are means ± s.d. or median (range) as appropriate.
 
 
 
Baseline (n = 23)
 
One year (n = 22)
% Change vs 
baseline
 
Two years (n = 23)
% Change vs 
baseline
Age (years) 42.6 ± 7.8 43.8 ± 7.8 – 44.7 ± 7.8 –
Sex (female/male) 14/9 14/9 – 14/9 –
Height (cm) 172 ± 9 – – – –
Weight (kg) 124 (108, 144) 95 (81, 112)b −24.1 94 (79, 110)b −25.2
Body mass index (kg/m2) 42 (38, 47) 31 (28, 37)b −24.1 31 (27, 36)b −25.2
Biochemistry      
 PTH (pmol/L) 5.1 (3.1, 7.3) 4.2 (2.7, 6.5) −9.7 4.8 (3.5, 6.4) −6.5
 25-OH-vitamin D2 + D3 (nmol/L) 34 ± 16 59 ± 15b 109.2 93 ± 32b,d 240.4
 P1NP (µg/L) 36 (29, 45) 80 (62, 93)b 113.6 78 (63, 103)b 112.9
 CTX-1 (µg/L) 0.42 ± 0.22 1.12 ± 0.48b 166.7 0.63 ± 0.35a,d 40.0
 Adiponectin (mg/L) 3.6 (3.0, 6.2) 7.4 (6.1, 11.5)b 109.6 5.9 (4.3, 8.4)b,d 62.0
 Leptin (ng/mL) 42 (27, 64) 10 (5, 29)b −70.0 9 (5, 11)b −77.2
 Insulin (pmol/L) 151 (117, 212) 48 (35, 56)b −68.0 40 (30, 51)b −73.5
DXA      
 Total hip aBMD (g/cm2) 1.11 ± 0.12 1.02 ± 0.14b −8.2 0.99 ± 0.15b,c −10.5
 Lumbar spine aBMD (g/cm2) 1.08 ± 0.14 1.04 ± 0.15b −3.5 1.03 ± 0.15b −5.3
 Total fat mass (kg) 56 ± 12 34 ± 11b −40.1 35 ± 10b −38.0
 Total lean mass (kg) 70 ± 14 61 ± 14b −13.1 61 ± 14b −13.0
 Total fat percent (%) 46 (38, 50) 37 (30, 42)b −21.0 38 (29, 43)b −19.1
a and b indicate significance of differences between the one year or two year values compared to baseline values and c and d indicate significance of 
differences between the two-year values compared to one-year values.
aP < 0.05, bP < 0.001, cP < 0.05, dP < 0.001.
aBMD, areal bone mineral density; CTX-1, C-terminal telopeptide of type 1 collagen; DXA, dual energy X-ray absorptiometry; HRT, hormone replacement 
therapy; PTH, parathyroid hormone; P1NP, procollagen type 1 amino-terminal propeptide.
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7.6% fall in trabecular vBMD (P < 0.001). Alongside the 
decline in trabecular vBMD there was a loss of entire 
trabeculae leading to a reduction in trabecular number 
(−4.3%, P < 0.05), increase in trabecular separation (7.5%, 
P < 0.05) and a greater trabecular network inhomogeneity 
(18.5%, P < 0.01). Although there was no significant 
change in cortical vBMD 24  months post-RYGB, there 
was a 2.9% decrease in cortical thickness (P < 0.01) and 
a 21.0% increase in cortical porosity (P < 0.05). Estimated 
failure load declined by 5.2% throughout the study 
period (P < 0.01). Of note, except for cortical area and 
cortical thickness where the rate of decline was most 
prominent at month 12, with stabilization from month 
12 to 24, the rate of loss of vBMD and deterioration of 
microarchitectural parameters were most pronounced in 
the second year post-RYGP (Fig. 2).
At the tibia, there was a persistent decrease in cortical 
area (−7.8%, P < 0.001) and a reciprocal increase in 
trabecular area (1.4%, P < 0.05) at month 24 from baseline. 
Total vBMD progressively declined throughout the study 
period (−7.2%, P < 0.001). This loss in total vBMD was due 
Table 2 Bone geometry, vBMD, microarchitecture and estimated strength using HR-pQCT in patients at baseline and one and 
two years after gastric bypass surgery. Data are means ± s.d. or median (range) as appropriate.
 Baseline (n = 23) One year (n = 22) Two years (n = 23)
Radius    
 Cortical area (mm2) 69 ± 14 68 ± 15a 67 ± 15b
 Cortical thickness (mm) 0.94 ± 0.15 0.92 ± 0.16a 0.91 ± 0.15b
 Cortical porosity (%) 1.38 (0.79, 2.44) 1.37 (0.91, 1.83) 1.78 (0.94, 2.64)d
 Trabecular area (mm2) 244 ± 89 247 ± 91 245 ± 89
 Total vBMD (mg/cm3) 354 ± 47 351 ± 45 339 ± 46c,f
 Cortical vBMD (mg/cm3) 906 ± 51 904 ± 52 900 ± 50
 Trabecular vBMD (mg/cm3) 175 ± 43 176 ± 40 162 ± 44c,f
 Trabecular number (1/mm) 2.20 (1.82, 2.41) 2.19 (2.00, 2.26) 2.09 (1.72, 2.34)a
 Trabecular thickness (mm) 0.066 (0.059, 0.080) 0.070 (0.064, 0.076) 0.063 (0.060, 0.075)
 Trabecular separation (mm) 0.383 (0.345, 0.488) 0.390 (0.373, 0.424) 0.398 (0.365, 0.538)a,d
 Trabecular network inhomogeneity (mm) 0.154 (0.131, 0.203) 0.161 (0.144, 0.170) 0.163 (0.140, 0.239)b,d
 Estimated failure load (N) 5000 ± 1450 4993 ± 1424 4757 ± 1461c,d
Tibia    
 Cortical area (mm2) 161 ± 34 157 ± 32c 149 ± 34c,f
 Cortical thickness (mm) 1.46 ± 0.22 1.41 ± 0.20c 1.34 ± 0.22c,f
 Cortical porosity (%) 5.45 ± 2.4 5.79 ± 2.8 6.56 ± 3.4c,e
 Trabecular area (mm2) 622 ± 152 628 ± 157a 630 ± 155c
 Total vBMD (mg/cm3) 341 ± 43 334 ± 47a 318 ± 53c,f
 Cortical vBMD (mg/cm3) 893 ± 42 881 ± 52a 871 ± 57c,e
 Trabecular vBMD (mg/cm3) 193 ± 38 189 ± 38 179 ± 40c,f
 Trabecular number (1/mm) 2.32 (2.09, 2.56) 2.22 (1.88, 2.50)c 2.18 (1.89, 2.42)c
 Trabecular thickness (mm) 0.071 (0.062, 0.075) 0.074 (0.064, 0.082) 0.073 (0.063, 0.080)
 Trabecular separation (mm) 0.354 (0.323, 0.419) 0.369 (0.332, 0.473)b 0.386 (0.340, 0.448)c
 Trabecular network inhomogeneity (mm) 0.142 (0.120, 0.182) 0.152 (0.131, 0.211)a 0.159 (0.130, 0.200)c
 Estimated failure load (N) 13 108 ± 2588 12 933 ± 2722 12 255 ± 2814c,f
a, b and c indicate significance of differences between the one-year or two-year values compared to baseline values and d, e and f indicate significance 
of differences between the two-year values compared to one-year values.
aP < 0.05, bP < 0.01, cP < 0.001, dP < 0.05, eP < 0.01, fP < 0.001.
vBMD, volumetric bone mineral density.
Figure 2
Percent change in HR-pQCT parameters in radius one 
(grey bars) and two years (black bars) after gastric bypass 
surgery. *P < 0.05, **P < 0.01, ***P < 0.001 vs baseline #P < 0.05, 
##P < 0.01, ###P < 0.001 vs one-year value. Trabecular net. 
inhomo, trabecular network inhomogeneity.
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to both, a decline in trabecular vBMD (−7.4%, P < 0.001) 
with reduced trabecular number (−8.7%, P < 0.001) , 
increased trabecular separation (8.0%, P < 0.001) and 
greater trabecular network inhomogeneity (16.1%, 
P < 0.001); and a reduction in cortical vBMD (−2.4%, 
P < 0.01) due to thinning of the cortex (−4.6%, P < 0.001) 
and an increase in cortical porosity (20.9%, P < 0.01). These 
changes lead to a compromise in the estimated failure load 
2-year post-RYGB (−7.0%, P < 0.001). Overall, the changes 
observed in trabecular geometrical and microarchitectural 
parameters were maximal in the first 12 months and then 
plateauing from month 12 to 24, whereas declines in 
cortical area, total and cortical vBMD generally progressed 
throughout the 2-year study period, and deteriorations in 
trabecular vBMD and estimated failure load were most 
conspicuous in the 12- to 24-month period (Fig. 3).
Predictors of bone loss
While baseline characteristics such as age and weight, 
change in weight from baseline to month 12 and change 
in the ratio of lean mass to fat mass were not the predictors 
of 24-month changes in DXA- or HR-pQCT-based bone 
parameters, changes in lean mass correlated with changes 
in total hip aBMD (rho 0.45, P = 0.03) and tibial cortical 
thickness (rho 0.47, P = 0.02), trabecular area (rho −0.44, 
P = 0.04) and trabecular network inhomogeneity (rho 
−0.47, P = 0.02). None of the changes in biochemical 
parameters from baseline to 24  months correlated with 
changes in DXA or HR-pQCT measures except a negative 
correlation between changes in adiponectin, CTX1, P1NP 
and changes in total hip aBMD (rho −0.44, P = 0.045; rho 
−0.59, P = 0.004 and rho −0.45, P = 0.038 respectively), 
changes in insulin and changes in estimated failure load 
(rho −0.48, P = 0.02) and positive correlation between 
changes in P1NP and cortical porosity (rho −0.62, P = 0.002) 
at the radius, and negative correlation between changes in 
P1NP and total and cortical vBMD and estimated failure 
load (rho −0.44, P = 0.039; rho −0.44, P = 0.039 and rho 
−0.52, P = 0.013 respectively) at the tibia.
Discussion
In contrast to our hypothesis, the findings from this study 
indicate a persistent decline in BMD and a progressive 
deterioration in bone microarchitecture and estimated 
strength at both weight bearing and non-weight bearing 
skeletal sites in the second year after Roux-en-Y gastric 
bypass. This continued and excessive bone loss persisted 
despite the attainment of steady-state in weight, fat 
and lean body mass, adipokines such as leptin and gut 
hormones such as insulin one year after surgery. There was 
no change in calcium or parathyroid hormone during the 
course of the study probably because of abundant vitamin 
D due to high daily supplementation doses. Overall, 
these results lend credence to the notion that adaptation 
of bone is a slow, ongoing process that continues after 
the stabilization of metabolic parameters and body 
weight such that attainment of skeletal equilibrium lags 
metabolic equilibrium.
Unlike the earlier findings of significant compromises 
in trabecular and cortical compartments at the tibia with 
only minimal changes at the radius 12  months post-
RYGB (15), extension of the current study into the second 
year demonstrated significant changes at both the radius 
and tibia. There were significant declines in total vBMD 
at both peripheral sites. While at the radius, this was 
manifest predominantly in the trabecular compartment 
with the loss of trabecular vBMD and microarchitectural 
deterioration, bone loss at the tibia was due to declines 
in both trabecular and cortical vBMD due to the loss of 
entire trabecular struts and a thinner, more porous cortex 
respectively. The magnitude of these changes resulted in 
significantly reduced estimated bone strength at both the 
skeletal sites examined. These findings are consistent with 
the previous two-year follow-up study by Yu  et  al. (10), 
who demonstrated an identical pattern of findings with 
predominantly trabecular bone loss at the radius and 
Figure 3
Percent change in HR-pQCT parameters in tibia one (grey bars) 
and two years (black bars) after gastric bypass surgery. 
*P < 0.05, **P < 0.01, ***P < 0.001 vs baseline #P < 0.05, 
##P < 0.01, ###P < 0.001 vs one-year value. Trabecular net. 
inhomo, trabecular network inhomogeneity.
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both, cortical and trabecular bone loss at the tibia, causing 
a reduced estimated bone strength at both sites. Similar 
to our study, Yu  et  al. (10) observed that the declines 
observed in BMD, microarchitecture and estimated bone 
strength in the first 12 months were matched or exceeded 
by declines in the 12- to 24-month period after gastric 
bypass.
The exact mechanisms underlying bone loss after 
RYGB are still unclear and probably multifactorial. 
While adaptive remodelling in response to mechanical 
unloading (20), failure to maintain lean muscle mass (21) 
and mal-absorption leading to changes in calciotropic 
hormones (22) are frequently cited, postoperative neuro-
hormonal and gut hormone alterations (23) also offer 
potential preliminary hypotheses. Adipose tissue has 
been increasingly recognized to harbour hormones 
(leptin, adiponectin and oestrogens, among others) with 
a substantial impact on bone metabolism (24). While 
there is some evidence that leptin is positively associated 
and adiponectin is negatively associated with aBMD 
(25, 26, 27), and the decrease in leptin and increase in 
adiponectin as seen after RYGB (28) would be anticipated 
to result in a decrease in bone mass, the ultimate effect 
of these adipokines on bone post-RYGB remains to 
be elucidated. Hyperinsulinaemia has been associated 
with a superior vBMD and microarchitecture (29). Thus 
a fall in insulin levels post-RYGB would be expected 
to negatively impact bone homeostasis. Although we 
did find significant decreases in leptin and insulin and 
increase in adiponectin in our study, we were unable to 
demonstrate consistent correlations between the changes 
in these hormones and the change in various bone 
parameters probably because of the limited sample size 
as well as the fact that deterioration in bone parameters 
was persistent throughout the 24  months study period 
while peak changes in adipokines and insulin was at 
month 12 followed by plateauing or no change from 
month 12 to 24.
Consistent with previous studies (6, 10), we found 
that changes in the cortical compartment were most 
conspicuous at the tibia whereas cortical vBMD was 
preserved at the radius. This disparate involvement of 
weight bearing and non-weight bearing skeletal sites in 
post gastric bypass patients may be caused by a complex 
interaction between biomechanical strains that are 
modulated by ambient oestrogen concentration in the 
bone microenvironment. As emphasized by Frost  et  al. 
(30) , chronically lowered strain levels, as seen in weight 
bearing bones post-RYGB, will induce a disuse mode of 
bone remodelling with an increased in bone turnover, 
predominantly at the endocortical surface. Reductions 
in serum oestrogen levels have been demonstrated in 
premenopausal women (31) and men (32) after bariatric 
surgery and there is accumulating evidence indicating 
that oestrogen has a more dominant role on the mature 
male skeleton (33). According to the threshold effect 
of bioavailable estradiol on cortical bone, as described 
by Khosla  et al. (33), non-weight bearing bones such as 
radius may have a lower sensitivity to oestrogen and thus 
a high threshold to withstand low oestrogen levels. Thus, 
the lesser impact of changes in mechanical loads on the 
radius coupled with the possibility that circulating levels 
of oestrogen in post-RYGB patients may be sufficiently 
high to maintain cortical integrity at the radius but not at 
the tibia is a potential explanation for the more marked 
loss of cortical bone at tibia compared to radius.
In our study, we found marked increases in bone 
turnover markers at 12 months that remained elevated, 
although less so, up to 24 months postoperatively despite 
the absence of secondary hyperparathyroidism. While 
this was in accordance with previous findings (10, 34), 
the increase in bone resorption markers exceeded levels 
typically observed during menopause transition (35). 
This, coupled with the incessant deterioration in vBMD 
and architecture after weight has stabilized, has led to 
the concern that patients are at an increased risk for 
osteoporosis and related future fracture post-bariatric 
surgery. The prevalence of osteopenia/osteoporosis 
after bariatric surgery is controversial with some studies 
suggesting lower BMD than expected (36) and others 
finding no difference compared with age- and post-
bariatric body mass index-matched controls (9, 37). 
Similarly, the risk of fractures in a bariatric surgery 
population is as yet unclear. While Lalmohamed et al. (38) 
reported no significant increase in fracture risk after three 
to five years following any bariatric surgery procedure, 
Lu et al. (39) showed increased fracture risks over a 12-year 
follow-up period restricted to mal-absorptive procedures 
such as gastric bypass but not restrictive procedures. On 
the other hand, Rousseau  et  al. (40) reported a higher 
likelihood of fractures only with biliopancreatic diversion 
but not RYGB or other procedures. Whether the increased 
fracture risk is a direct consequence of the type of bariatric 
surgery or an altered risk of falls due to changes in body 
composition or is reflective of an increased fracture 
incidence related to the underlying obesity and other 
comorbidities remains to be determined. Indeed, the 
paucity of fracture and osteoporosis incidence data raises 
questions about whether the marked bone loss after 
bariatric surgery is a physiological adaptation to skeletal 
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unloading or represents a pathophysiological process that 
may continue after weight stabilization inducing ongoing 
bone loss and increased bone fragility.
This study has some limitations including the lack of 
a nonsurgical control group to account for the age-related 
changes in bone loss, absence of data on physical activity, 
which may have played a role in the observed changes, as 
well as absence of biochemical measurements of other gut 
hormones that potentially affect bone metabolism. The 
lack of prospective studies examining changes in bone 
microarchitecture after gastric bypass surgery, at the time 
that this study was initiated, limited an adequate power 
calculation. Thus, although the relatively small number 
of premenopausal women and men in the study limited 
statistical power and precluded the generalizability of 
our results to postmenopausal women, the concordance 
of our results with previous HR-pQCT studies suggest 
otherwise (6, 10).
In summary, we found persistent declines in 
volumetric BMD and compromised microarchitectural 
integrity and estimated bone strength at the appendicular 
skeleton in the second year after RYGB surgery. This 
skeletal deterioration was progressive despite weight 
stabilization and maintenance of fat and lean mass and 
various other metabolic parameters. Future long-term 
studies are required to verify continued bone loss after 
bariatric surgery and evaluate the long-term effects on 
the skeleton in terms of increased risks of developing 
osteoporosis and fragility fractures.
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